Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-03-28 @ 1:05 PM
Study NCT ID:
NCT00979095
Status:
UNKNOWN
Last Update Posted:
2010-10-13
First Post:
2009-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genetic Examination of Patients With Primary Multiple Hernia
Sponsor:
Herlev Hospital
Organization:
Study Overview
Official Title:
Genetic Differences Between Patients With Multiple Hernia and a Healthy Control Group
Status:
UNKNOWN
Status Verified Date:
2010-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators are performing a genetic study of patients with multiple hernias (at least 3 primary hernias) versus a healthy control group. This genetic information is compared with circulating and subcutaneously biomarkers such as matrix-metalloproteinases (MMP's).
The hypothesis is that patients with multiple hernias have different expression of specific genes compared to the healthy control group.
The hypothesis is that patients with multiple hernias have different expression of specific genes compared to the healthy control group.
Detailed Description:
Other examinations performed on the patients enrolled in this study:
* Ultrasound (US) examination of the abdominal aorta to discover possible abdominal aortic aneurysms.
* Beightons score to evaluate the degree of joint hypermobility.
* Ultrasound (US) examination of the abdominal aorta to discover possible abdominal aortic aneurysms.
* Beightons score to evaluate the degree of joint hypermobility.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: